ClinicalTrials.Veeva

Menu

Autosomal Dominant Spinocerebellar Ataxias and Social Cognition (SoCoSca)

U

University Hospital, Angers

Status

Enrolling

Conditions

Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)

Treatments

Other: tests

Study type

Interventional

Funder types

Other

Identifiers

NCT07099651
ID-RCB 2025-A01253-46 (Other Identifier)
49RC23-0390

Details and patient eligibility

About

Spinocerebellar ataxias are a group of rare neurodegenerative diseases, clinically and genetically highly heterogeneous, with an estimated mean prevalence of 2.7 per 100,000 population. The term "spinocerebellar ataxia" or "SCA" is often used for ataxias of genetic origin of autosomal dominant transmission, which are the subject of this study. Recent studies of social cognition in patients with genetic cerebellar pathologies, and autosomal dominant spinocerebellar ataxia in particular, are still few and far between (around 15 studies), and seem to highlight impairment of basic emotion recognition and theory of mind skills. That said, data have very often been collected on very small samples of patients (sometimes in case study format). They also remain contradictory, including in the examination of the cerebellar anatomoclinical correlates of the deficits. Thus, the question arises as to whether patients with spinocerebellar ataxia also show impairments in emotion recognition and cognitive and affective theory of mind in more ecologically valid dynamic and interactive assessment situations.

Enrollment

160 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For all participants:

  • Men or women aged 18 and over
  • At least 7 years' schooling (CEP level)
  • Ability to read, write and speak French
  • Signed informed consent to participate in the study

For patients :

- With molecularly confirmed autosomal dominant spinocerebellar ataxia (SCA1, 2, 3, 6, 7, 27B)

For controls:

- With no neurological pathology (questioning and neurological examination)

Exclusion criteria

For patients and controls:

  • Simultaneous participation in another protocol that may interfere with the measurement of the criteria of interest
  • Physical or cultural factors likely to interfere with test performance
  • History likely to interfere with cognition (stroke, cranioencephalic trauma, other neurodegenerative disease, epilepsy, learning disability, alcohol dependence syndrome, psychiatric disorders...)
  • Persons with contraindications to MRI scans
  • Pregnant, nursing or parturient women
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons under compulsory psychiatric care
  • Persons subject to a legal protection measure
  • Persons unable to express their consent
  • Persons not affiliated to or not benefiting from a social security scheme (beneficiary or beneficiary entitled)

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

160 participants in 2 patient groups

patients autosomal dominant spinocerebellar ataxia
Active Comparator group
Treatment:
Other: tests
healthy patients
Active Comparator group
Treatment:
Other: tests

Trial contacts and locations

1

Loading...

Central trial contact

Philippe Allain, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems